Abstract
Evidence from the literature indicated that approximately 500,000 diagnoses of hypertension were missed in Great Britain due to the COVID-19 pandemic, over April 2018–July 2021. However, it remains unclear if this trend of misdiagnosis/ undiagnosed cases persisted beyond July 2021 or if the healthcare system successfully caught up with these missed diagnoses. This insight is crucial, as ongoing issues would require urgent attention.
Original language | English |
---|---|
Number of pages | 1 |
Publication status | Published - 1 May 2024 |
Event | Scottish Public Health Conference 2024 - The Technology and Innovation Centre, University of Strathclyde, Glasgoq, United Kingdom Duration: 1 May 2024 → 1 May 2024 |
Conference
Conference | Scottish Public Health Conference 2024 |
---|---|
Country/Territory | United Kingdom |
City | Glasgoq |
Period | 1/05/24 → 1/05/24 |
Keywords
- hypertension
- hypercholesterolaemia
- Covid-19
- diagnosis